Desipramine
Desipramine, sold under the brand name Norpramin among others, is a tricyclic antidepressant (TCA) used in the treatment of depression. It acts as a relatively selective norepinephrine reuptake inhibitor, though it does also have other activities such as weak serotonin reuptake inhibitory, α1-blocking, antihistamine, and anticholinergic effects. The drug is not considered a first-line treatment for depression since the introduction of selective serotonin reuptake inhibitor (SSRI) antidepressants, which have fewer side effects and are safer in overdose.
Clinical data | |
---|---|
Trade names | Norpramin, Pertofrane, others |
Other names | Desmethylimipramine; Norimipramine; EX-4355; G-35020; JB-8181; NSC-114901 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682387 |
Routes of administration | Oral, intramuscular injection |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 60–70% |
Protein binding | 91% |
Metabolism | Liver (CYP2D6) |
Elimination half-life | 12–30 hours |
Excretion | Urine (70%), feces |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.037 |
Chemical and physical data | |
Formula | C18H22N2 |
Molar mass | 266.388 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.